Serveur d'exploration sur la rapamycine et les champignons

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast.

Identifieur interne : 001B54 ( Main/Exploration ); précédent : 001B53; suivant : 001B55

Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast.

Auteurs : J. Heitman [Suisse] ; N R Movva ; M N Hall

Source :

RBID : pubmed:1715094

Descripteurs français

English descriptors

Abstract

FK506 and rapamycin are related immunosuppressive compounds that block helper T cell activation by interfering with signal transduction. In vitro, both drugs bind and inhibit the FK506-binding protein (FKBP) proline rotamase. Saccharomyces cerevisiae cells treated with rapamycin irreversibly arrested in the G1 phase of the cell cycle. An FKBP-rapamycin complex is concluded to be the toxic agent because (i) strains that lack FKBP proline rotamase, encoded by FPR1, were viable and fully resistant to rapamycin and (ii) FK506 antagonized rapamycin toxicity in vivo. Mutations that conferred rapamycin resistance altered conserved residues in FKBP that are critical for drug binding. Two genes other than FPR1, named TOR1 and TOR2, that participate in rapamycin toxicity were identified. Nonallelic noncomplementation between FPR1, TOR1, and TOR2 alleles suggests that the products of these genes may interact as subunits of a protein complex. Such a complex may mediate nuclear entry of signals required for progression through the cell cycle.

DOI: 10.1126/science.1715094
PubMed: 1715094


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast.</title>
<author>
<name sortKey="Heitman, J" sort="Heitman, J" uniqKey="Heitman J" first="J" last="Heitman">J. Heitman</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Biochemistry, University of Basel, Switzerland.</nlm:affiliation>
<country xml:lang="fr">Suisse</country>
<wicri:regionArea>Department of Biochemistry, University of Basel</wicri:regionArea>
<wicri:noRegion>University of Basel</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Movva, N R" sort="Movva, N R" uniqKey="Movva N" first="N R" last="Movva">N R Movva</name>
</author>
<author>
<name sortKey="Hall, M N" sort="Hall, M N" uniqKey="Hall M" first="M N" last="Hall">M N Hall</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="1991">1991</date>
<idno type="RBID">pubmed:1715094</idno>
<idno type="pmid">1715094</idno>
<idno type="doi">10.1126/science.1715094</idno>
<idno type="wicri:Area/Main/Corpus">001B55</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">001B55</idno>
<idno type="wicri:Area/Main/Curation">001B55</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">001B55</idno>
<idno type="wicri:Area/Main/Exploration">001B55</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast.</title>
<author>
<name sortKey="Heitman, J" sort="Heitman, J" uniqKey="Heitman J" first="J" last="Heitman">J. Heitman</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Biochemistry, University of Basel, Switzerland.</nlm:affiliation>
<country xml:lang="fr">Suisse</country>
<wicri:regionArea>Department of Biochemistry, University of Basel</wicri:regionArea>
<wicri:noRegion>University of Basel</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Movva, N R" sort="Movva, N R" uniqKey="Movva N" first="N R" last="Movva">N R Movva</name>
</author>
<author>
<name sortKey="Hall, M N" sort="Hall, M N" uniqKey="Hall M" first="M N" last="Hall">M N Hall</name>
</author>
</analytic>
<series>
<title level="j">Science (New York, N.Y.)</title>
<idno type="ISSN">0036-8075</idno>
<imprint>
<date when="1991" type="published">1991</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Amino Acid Sequence (MeSH)</term>
<term>Anti-Bacterial Agents (metabolism)</term>
<term>Anti-Bacterial Agents (pharmacology)</term>
<term>Base Sequence (MeSH)</term>
<term>Binding Sites (MeSH)</term>
<term>Carrier Proteins (antagonists & inhibitors)</term>
<term>Carrier Proteins (chemistry)</term>
<term>Carrier Proteins (genetics)</term>
<term>Carrier Proteins (metabolism)</term>
<term>Cell Cycle (drug effects)</term>
<term>Cyclosporins (pharmacology)</term>
<term>Drug Resistance, Microbial (genetics)</term>
<term>G1 Phase (drug effects)</term>
<term>Humans (MeSH)</term>
<term>Immunosuppressive Agents (pharmacology)</term>
<term>Molecular Sequence Data (MeSH)</term>
<term>Molecular Structure (MeSH)</term>
<term>Mutation (MeSH)</term>
<term>Polyenes (metabolism)</term>
<term>Polyenes (pharmacology)</term>
<term>Saccharomyces cerevisiae (cytology)</term>
<term>Saccharomyces cerevisiae (drug effects)</term>
<term>Sequence Homology, Nucleic Acid (MeSH)</term>
<term>Signal Transduction (MeSH)</term>
<term>Sirolimus (MeSH)</term>
<term>Tacrolimus (MeSH)</term>
<term>Tacrolimus Binding Proteins (MeSH)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Antibactériens (métabolisme)</term>
<term>Antibactériens (pharmacologie)</term>
<term>Cycle cellulaire (effets des médicaments et des substances chimiques)</term>
<term>Cyclosporines (pharmacologie)</term>
<term>Données de séquences moléculaires (MeSH)</term>
<term>Humains (MeSH)</term>
<term>Immunosuppresseurs (pharmacologie)</term>
<term>Mutation (MeSH)</term>
<term>Phase G1 (effets des médicaments et des substances chimiques)</term>
<term>Polyènes (métabolisme)</term>
<term>Polyènes (pharmacologie)</term>
<term>Protéines de liaison au tacrolimus (MeSH)</term>
<term>Protéines de transport (antagonistes et inhibiteurs)</term>
<term>Protéines de transport (composition chimique)</term>
<term>Protéines de transport (génétique)</term>
<term>Protéines de transport (métabolisme)</term>
<term>Résistance microbienne aux médicaments (génétique)</term>
<term>Saccharomyces cerevisiae (cytologie)</term>
<term>Saccharomyces cerevisiae (effets des médicaments et des substances chimiques)</term>
<term>Similitude de séquences d'acides nucléiques (MeSH)</term>
<term>Sirolimus (MeSH)</term>
<term>Sites de fixation (MeSH)</term>
<term>Structure moléculaire (MeSH)</term>
<term>Séquence d'acides aminés (MeSH)</term>
<term>Séquence nucléotidique (MeSH)</term>
<term>Tacrolimus (MeSH)</term>
<term>Transduction du signal (MeSH)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="antagonists & inhibitors" xml:lang="en">
<term>Carrier Proteins</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="chemistry" xml:lang="en">
<term>Carrier Proteins</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en">
<term>Carrier Proteins</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en">
<term>Anti-Bacterial Agents</term>
<term>Carrier Proteins</term>
<term>Polyenes</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en">
<term>Anti-Bacterial Agents</term>
<term>Cyclosporins</term>
<term>Immunosuppressive Agents</term>
<term>Polyenes</term>
</keywords>
<keywords scheme="MESH" qualifier="antagonistes et inhibiteurs" xml:lang="fr">
<term>Protéines de transport</term>
</keywords>
<keywords scheme="MESH" qualifier="composition chimique" xml:lang="fr">
<term>Protéines de transport</term>
</keywords>
<keywords scheme="MESH" qualifier="cytologie" xml:lang="fr">
<term>Saccharomyces cerevisiae</term>
</keywords>
<keywords scheme="MESH" qualifier="cytology" xml:lang="en">
<term>Saccharomyces cerevisiae</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en">
<term>Cell Cycle</term>
<term>G1 Phase</term>
<term>Saccharomyces cerevisiae</term>
</keywords>
<keywords scheme="MESH" qualifier="effets des médicaments et des substances chimiques" xml:lang="fr">
<term>Cycle cellulaire</term>
<term>Phase G1</term>
<term>Saccharomyces cerevisiae</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en">
<term>Drug Resistance, Microbial</term>
</keywords>
<keywords scheme="MESH" qualifier="génétique" xml:lang="fr">
<term>Protéines de transport</term>
<term>Résistance microbienne aux médicaments</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr">
<term>Antibactériens</term>
<term>Polyènes</term>
<term>Protéines de transport</term>
</keywords>
<keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr">
<term>Antibactériens</term>
<term>Cyclosporines</term>
<term>Immunosuppresseurs</term>
<term>Polyènes</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Amino Acid Sequence</term>
<term>Base Sequence</term>
<term>Binding Sites</term>
<term>Humans</term>
<term>Molecular Sequence Data</term>
<term>Molecular Structure</term>
<term>Mutation</term>
<term>Sequence Homology, Nucleic Acid</term>
<term>Signal Transduction</term>
<term>Sirolimus</term>
<term>Tacrolimus</term>
<term>Tacrolimus Binding Proteins</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Données de séquences moléculaires</term>
<term>Humains</term>
<term>Mutation</term>
<term>Protéines de liaison au tacrolimus</term>
<term>Similitude de séquences d'acides nucléiques</term>
<term>Sirolimus</term>
<term>Sites de fixation</term>
<term>Structure moléculaire</term>
<term>Séquence d'acides aminés</term>
<term>Séquence nucléotidique</term>
<term>Tacrolimus</term>
<term>Transduction du signal</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">FK506 and rapamycin are related immunosuppressive compounds that block helper T cell activation by interfering with signal transduction. In vitro, both drugs bind and inhibit the FK506-binding protein (FKBP) proline rotamase. Saccharomyces cerevisiae cells treated with rapamycin irreversibly arrested in the G1 phase of the cell cycle. An FKBP-rapamycin complex is concluded to be the toxic agent because (i) strains that lack FKBP proline rotamase, encoded by FPR1, were viable and fully resistant to rapamycin and (ii) FK506 antagonized rapamycin toxicity in vivo. Mutations that conferred rapamycin resistance altered conserved residues in FKBP that are critical for drug binding. Two genes other than FPR1, named TOR1 and TOR2, that participate in rapamycin toxicity were identified. Nonallelic noncomplementation between FPR1, TOR1, and TOR2 alleles suggests that the products of these genes may interact as subunits of a protein complex. Such a complex may mediate nuclear entry of signals required for progression through the cell cycle.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">1715094</PMID>
<DateCompleted>
<Year>1991</Year>
<Month>09</Month>
<Day>25</Day>
</DateCompleted>
<DateRevised>
<Year>2019</Year>
<Month>06</Month>
<Day>18</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0036-8075</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>253</Volume>
<Issue>5022</Issue>
<PubDate>
<Year>1991</Year>
<Month>Aug</Month>
<Day>23</Day>
</PubDate>
</JournalIssue>
<Title>Science (New York, N.Y.)</Title>
<ISOAbbreviation>Science</ISOAbbreviation>
</Journal>
<ArticleTitle>Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast.</ArticleTitle>
<Pagination>
<MedlinePgn>905-9</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>FK506 and rapamycin are related immunosuppressive compounds that block helper T cell activation by interfering with signal transduction. In vitro, both drugs bind and inhibit the FK506-binding protein (FKBP) proline rotamase. Saccharomyces cerevisiae cells treated with rapamycin irreversibly arrested in the G1 phase of the cell cycle. An FKBP-rapamycin complex is concluded to be the toxic agent because (i) strains that lack FKBP proline rotamase, encoded by FPR1, were viable and fully resistant to rapamycin and (ii) FK506 antagonized rapamycin toxicity in vivo. Mutations that conferred rapamycin resistance altered conserved residues in FKBP that are critical for drug binding. Two genes other than FPR1, named TOR1 and TOR2, that participate in rapamycin toxicity were identified. Nonallelic noncomplementation between FPR1, TOR1, and TOR2 alleles suggests that the products of these genes may interact as subunits of a protein complex. Such a complex may mediate nuclear entry of signals required for progression through the cell cycle.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Heitman</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Department of Biochemistry, University of Basel, Switzerland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Movva</LastName>
<ForeName>N R</ForeName>
<Initials>NR</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Hall</LastName>
<ForeName>M N</ForeName>
<Initials>MN</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Science</MedlineTA>
<NlmUniqueID>0404511</NlmUniqueID>
<ISSNLinking>0036-8075</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D002352">Carrier Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D003524">Cyclosporins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D007166">Immunosuppressive Agents</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D011090">Polyenes</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 5.2.1.-</RegistryNumber>
<NameOfSubstance UI="D022021">Tacrolimus Binding Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>W36ZG6FT64</RegistryNumber>
<NameOfSubstance UI="D020123">Sirolimus</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>WM0HAQ4WNM</RegistryNumber>
<NameOfSubstance UI="D016559">Tacrolimus</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<GeneSymbolList>
<GeneSymbol>FPR1</GeneSymbol>
<GeneSymbol>TOR1</GeneSymbol>
<GeneSymbol>TOR2</GeneSymbol>
</GeneSymbolList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000595" MajorTopicYN="N">Amino Acid Sequence</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000900" MajorTopicYN="N">Anti-Bacterial Agents</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
<QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D001483" MajorTopicYN="N">Base Sequence</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D001665" MajorTopicYN="N">Binding Sites</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002352" MajorTopicYN="N">Carrier Proteins</DescriptorName>
<QualifierName UI="Q000037" MajorTopicYN="N">antagonists & inhibitors</QualifierName>
<QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002453" MajorTopicYN="N">Cell Cycle</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D003524" MajorTopicYN="N">Cyclosporins</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D004352" MajorTopicYN="N">Drug Resistance, Microbial</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D016193" MajorTopicYN="N">G1 Phase</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007166" MajorTopicYN="N">Immunosuppressive Agents</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008969" MajorTopicYN="N">Molecular Sequence Data</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D015394" MajorTopicYN="N">Molecular Structure</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011090" MajorTopicYN="N">Polyenes</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
<QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D012441" MajorTopicYN="N">Saccharomyces cerevisiae</DescriptorName>
<QualifierName UI="Q000166" MajorTopicYN="Y">cytology</QualifierName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D012689" MajorTopicYN="N">Sequence Homology, Nucleic Acid</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D020123" MajorTopicYN="N">Sirolimus</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D016559" MajorTopicYN="N">Tacrolimus</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D022021" MajorTopicYN="N">Tacrolimus Binding Proteins</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="pubmed">
<Year>1991</Year>
<Month>8</Month>
<Day>23</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>1991</Year>
<Month>8</Month>
<Day>23</Day>
<Hour>0</Hour>
<Minute>1</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>1991</Year>
<Month>8</Month>
<Day>23</Day>
<Hour>0</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">1715094</ArticleId>
<ArticleId IdType="doi">10.1126/science.1715094</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>Suisse</li>
</country>
</list>
<tree>
<noCountry>
<name sortKey="Hall, M N" sort="Hall, M N" uniqKey="Hall M" first="M N" last="Hall">M N Hall</name>
<name sortKey="Movva, N R" sort="Movva, N R" uniqKey="Movva N" first="N R" last="Movva">N R Movva</name>
</noCountry>
<country name="Suisse">
<noRegion>
<name sortKey="Heitman, J" sort="Heitman, J" uniqKey="Heitman J" first="J" last="Heitman">J. Heitman</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Bois/explor/RapamycinFungusV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001B54 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001B54 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Bois
   |area=    RapamycinFungusV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:1715094
   |texte=   Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:1715094" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a RapamycinFungusV1 

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Thu Nov 19 21:55:41 2020. Site generation: Thu Nov 19 22:00:39 2020